Resilient Drug Supply

The Resilient Drug Supply project (funded by a gift from the Walton Family Foundation) is the first end-to-end comprehensive effort to define and address vulnerabilities to the public health resulting from medical drug shortages. The primary goal is to make the medical and drug supply chain resilient to drug shortages to ensure reliable delivery of the right medication to the right person at the right time. Project activities will be focused on identifying a list of critical acute drugs, characterizing the production of these critical drugs, and convening national experts for two workshops that support these efforts.

Critical drugs are those needed in the acute care setting and for which their absence, or the lack of availability of an effective substitute, will lead to serious health outcomes, including death or the inability to provide humane care. The drug characterization profiles include information on sources for the procurement of the active pharmaceutical ingredient (API) and an initial mapping of the drug supply chain that traces the product from raw chemicals to finished drug to patient. 

This project is led by Co-Principal Investigators Dr. Michael Osterholm and Dr. Stephen Schondelmeyer, with support from the drug supply team staff members.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation Gilead Become an underwriter»